Rankings
▼
Calendar
XERS Q4 2017 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena
XERS
Xeris Biopharma Holdings, Inc.
$982M
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$467,000
Gross Profit
$467,000
100.0% margin
Operating Income
-$9M
-1971.9% margin
Net Income
-$9M
-1958.5% margin
EPS (Diluted)
$-4.43
QoQ Revenue Growth
+174.7%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$148,000
Balance Sheet
Total Assets
$45M
Total Liabilities
$103M
Stockholders' Equity
-$58M
Cash & Equivalents
$42M
← FY 2017
All Quarters
Q1 2018 →
